×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
COCP – cocrystal pharma, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
COCP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
08:17 am
cocp
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus [Yahoo! Finance]
Medium
Report
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus [Yahoo! Finance]
12/18
08:00 am
cocp
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
Medium
Report
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
12/1
08:10 am
cocp
Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference [Yahoo! Finance]
Low
Report
Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference [Yahoo! Finance]
12/1
08:00 am
cocp
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
Low
Report
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
11/19
01:17 pm
cocp
Cocrystal Pharma (NASDAQ:COCP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Cocrystal Pharma (NASDAQ:COCP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/14
07:08 pm
cocp
Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs [Yahoo! Finance]
Low
Report
Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs [Yahoo! Finance]
11/14
08:36 am
cocp
Cocrystal Pharma GAAP EPS of -$0.19 beats by $0.02 [Seeking Alpha]
Low
Report
Cocrystal Pharma GAAP EPS of -$0.19 beats by $0.02 [Seeking Alpha]
11/14
08:00 am
cocp
Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Neutral
Report
Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/18
09:00 am
cocp
Form 8-K Cocrystal Pharma, Inc. For: Dec 18
Medium
Report
Form 8-K Cocrystal Pharma, Inc. For: Dec 18
12/1
04:30 pm
cocp
Form 8-K Cocrystal Pharma, Inc. For: Dec 01
Medium
Report
Form 8-K Cocrystal Pharma, Inc. For: Dec 01
11/28
09:00 am
cocp
Form 4 Cocrystal Pharma, Inc. For: Nov 26 Filed by: FROST PHILLIP MD ET AL
Medium
Report
Form 4 Cocrystal Pharma, Inc. For: Nov 26 Filed by: FROST PHILLIP MD ET AL
11/25
08:17 pm
cocp
Form 4 Cocrystal Pharma, Inc. For: Nov 25 Filed by: FROST PHILLIP MD ET AL
Low
Report
Form 4 Cocrystal Pharma, Inc. For: Nov 25 Filed by: FROST PHILLIP MD ET AL
11/14
08:30 am
cocp
Form 8-K Cocrystal Pharma, Inc. For: Nov 14
Low
Report
Form 8-K Cocrystal Pharma, Inc. For: Nov 14
11/14
08:01 am
cocp
Form 10-Q Cocrystal Pharma, Inc. For: Sep 30
Low
Report
Form 10-Q Cocrystal Pharma, Inc. For: Sep 30
10/30
04:42 pm
cocp
Form SCHEDULE 13D/A Cocrystal Pharma, Inc. Filed by: FROST PHILLIP MD ET AL
Low
Report
Form SCHEDULE 13D/A Cocrystal Pharma, Inc. Filed by: FROST PHILLIP MD ET AL
10/30
04:15 pm
cocp
Form 4 Cocrystal Pharma, Inc. For: Oct 28 Filed by: FROST PHILLIP MD ET AL
Neutral
Report
Form 4 Cocrystal Pharma, Inc. For: Oct 28 Filed by: FROST PHILLIP MD ET AL
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/24
Cocrystal Pharma, Inc. Announces License Agreement with Kansas State University Research Foundation for Norovirus and Coronavirus Antiviral Compounds
129.3%
3/6 Cocrystal Pharma Announces Plans to Advance Coronavirus Program 18.6%
10/16 Is Cocrystal Pharma, Inc. (NASDAQ:COCP) Overpaying Its CEO? [Yahoo! Finance News] 14.5%
3/11 Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market 11.5%
1/31 Form 8-K Cocrystal Pharma, Inc. For: Jan 29 10.0%
2/27 Form SC 13G Cocrystal Pharma, Inc. Filed by: SABBY MANAGEMENT, LLC 9.4%
2/28 Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market 8.6%
10/29 Form 4 Cocrystal Pharma, Inc. For: Oct 23 Filed by: Schinazi Raymond F 7.5%
4/15 Cocrystal Pharma to Present at the April 2020 Virtual Investor Summit 7.5%
2/18 Form 8-K Cocrystal Pharma, Inc. For: Feb 18 5.6%
3/6 Cocrystal Pharma Announces Plans to Advance Coronavirus Program 18.6%
10/16 Is Cocrystal Pharma, Inc. (NASDAQ:COCP) Overpaying Its CEO? [Yahoo! Finance News] 14.5%
3/11 Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market 11.5%
1/31 Form 8-K Cocrystal Pharma, Inc. For: Jan 29 10.0%
2/27 Form SC 13G Cocrystal Pharma, Inc. Filed by: SABBY MANAGEMENT, LLC 9.4%
2/28 Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market 8.6%
10/29 Form 4 Cocrystal Pharma, Inc. For: Oct 23 Filed by: Schinazi Raymond F 7.5%
4/15 Cocrystal Pharma to Present at the April 2020 Virtual Investor Summit 7.5%
2/18 Form 8-K Cocrystal Pharma, Inc. For: Feb 18 5.6%
TOP News Decliners
10/30
COCRYSTAL PHARMA, INC. ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK
-35.5%
3/9 Cocrystal Pharma Announces $6.8 Million Registered Direct Offering Priced At-the-Market -30.7%
11/12 Form 10-Q Cocrystal Pharma, Inc. For: Sep 30 -26.8%
4/22 Form 8-K Cocrystal Pharma, Inc. For: Apr 19 -26.6%
1/29 COCRYSTAL PHARMA, INC. PRICES $2.2 MILLION REGISTERED DIRECT OFFERING -16.9%
3/13 Form 8-K Cocrystal Pharma, Inc. For: Mar 09 -14.8%
2/3 COCRYSTAL PHARMA, INC. ANNOUNCES CLOSING OF $2.2 MILLION REGISTERED DIRECT OFFERING -13.3%
2/27 Cocrystal Pharma Announces $11.0 Million Registered Direct Offering Priced At-the-Market -12.9%
8/9 Form 10-Q Cocrystal Pharma, Inc. For: Jun 30 -12.2%
3/30 Form 8-K Cocrystal Pharma, Inc. For: Mar 30 -10.3%
3/9 Cocrystal Pharma Announces $6.8 Million Registered Direct Offering Priced At-the-Market -30.7%
11/12 Form 10-Q Cocrystal Pharma, Inc. For: Sep 30 -26.8%
4/22 Form 8-K Cocrystal Pharma, Inc. For: Apr 19 -26.6%
1/29 COCRYSTAL PHARMA, INC. PRICES $2.2 MILLION REGISTERED DIRECT OFFERING -16.9%
3/13 Form 8-K Cocrystal Pharma, Inc. For: Mar 09 -14.8%
2/3 COCRYSTAL PHARMA, INC. ANNOUNCES CLOSING OF $2.2 MILLION REGISTERED DIRECT OFFERING -13.3%
2/27 Cocrystal Pharma Announces $11.0 Million Registered Direct Offering Priced At-the-Market -12.9%
8/9 Form 10-Q Cocrystal Pharma, Inc. For: Jun 30 -12.2%
3/30 Form 8-K Cocrystal Pharma, Inc. For: Mar 30 -10.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: